Joseph R. Taylor
Bristol-Myers Squibb (Germany)(DE)Angelo State University(US)Bristol-Myers Squibb (United States)(US)Bristol-Myers Squibb (Sweden)(SE)
Publications by Year
Research Areas
Hormonal Regulation and Hypertension, Diabetes Treatment and Management, Pancreatic function and diabetes, Pharmacogenetics and Drug Metabolism, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Most-Cited Works
- → Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes(2008)617 cited
- → Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats(2008)417 cited
- → Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses(2001)239 cited
- → Novel Benzofuran and Benzothiophene Biphenyls as Inhibitors of Protein Tyrosine Phosphatase 1B with Antihyperglycemic Properties(2000)210 cited
- → Eleven Amino Acid Glucagon-like Peptide-1 Receptor Agonists with Antidiabetic Activity(2009)71 cited
- → Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases(2021)55 cited